research on cryptocurrency Top Block

Big move! Two billion M&A and restructuring funds in Shanghai have come to target the chip and pharmaceutical industries.Big move! Two billion M&A and restructuring funds in Shanghai have come to target the chip and pharmaceutical industries.The "Action Plan" proposes to strive to land a number of representative M&A cases in key industries by 2027, and cultivate about 10 internationally competitive listed companies in key industries such as integrated circuits, biomedicine and new materials.

For the biomedical industry, Bu Rixin told the reporter of science and technology innovation board Daily that the investment cycle of biomedicine is generally long, and it needs to go through multiple stages from research and development to listing."Because the industry is a typical' big money' industry, that is, high risk, long cycle and burning money, the nature of biomedicine also determines that it needs mergers and acquisitions in the current environment to become bigger and stronger."Big move! Two billion M&A and restructuring funds in Shanghai have come to target the chip and pharmaceutical industries.

However, in the field of large chips such as GPU, it has not yet run out of listed companies. It can be seen that Moore Thread, Biwa Technology, Suiyuan Technology, etc. have started the listing counseling process one after another.At the end of the year, Shanghai launched a big action in the field of mergers and acquisitions. Today, the General Office of the Shanghai Municipal People's Government issued the Action Plan for Shanghai to Support the Merger and Reorganization of Listed Companies (2025-2027) (hereinafter referred to as the Action Plan).Since then, after continuing to Shenzhen and Anhui, Shanghai has also made efforts in mergers and acquisitions.